Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials recruiting in California

Fewer than 3 recruiting trials found.

All Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials nationally

Cities in California

Recruiting trials in California

• Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
  NCT07140900 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: San Francisco